PERSPECTA

News from every angle

← Back to headlines

Jim Cramer Advises Caution on ImmunityBio

Jim Cramer recommended waiting for more clarity regarding ImmunityBio before investors consider a serious evaluation of the company's stock.

21 Apr, 17:19 — 21 Apr, 17:19
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual7h ago

Jim Cramer Suggests Waiting for Clarity on ImmunityBio Before Taking a “Hard Look”

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

UACN Lists N54.03bn Bond on Nigerian Exchange

just now

Standard Chartered recognised for leadership in M&A

24m ago

Gates Foundation says it has opened external review of Epstein ties

27m ago